Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus CD2 for Mucositis in HSCT
NCT01797952Phase 3Withdrawn
- Sponsor
- AIIMS New Delhi
- Start
- Nov 2015
- Primary completion
- Oct 2016
- Modality
- Yeast Strains, Defined Consortia, Bacterial Strains
- Countries
- 1
01
Overview
A Phase 3 trial of lactobacillus brevis cd2 in oral mucositis (OM), sponsored by AIIMS New Delhi. Planned start Nov 2015; status: withdrawn.
02
Drugs
lactobacillus brevis cd2
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT01797952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01797952.